Sinonasal Malign Melanoma: A Rare Case Report
1Hatay Mustafa Kemal Üniversitesi Tıp Fakültesi Hastanesi, Patoloji Anabilim Dalı, Hatay, Türkiye
2Hatay Mustafa Kemal Üniversitesi Tıp Fakültesi Hastanesi, Kulak Burun Boğaz Hastalıkları Anabilim Dalı, Hatay, Türkiye
Keywords: Malign Melanom, Nazal Kavite, Sinonazal, Malign Melanoma, Nasal Cavity, Sinonasal
998 görüntülenme 886 indirme
Introduction
In the present report, we have presented the 64-year-old female patient diagnosed with sinonasal malignant melanoma.
Case Report
Figure 1: Tumor cells forming solid islands and nidations(H+E, x200).
Melanin pigment was remarkable in the cytoplasm of some tumor cells (Figure 2).
Figure 2: Melanin pigment in the cytoplasm (H+E, x400).
Necrosis was present. The immunohistochemical examination demonstrated positive immunoreactivity with S100, HMB45 and MelanA in the tumor cells (Figure 3).
Figure 3: Positivity with HMB45 in the tumor cells (HMB45, x200).
No immunoreactivity with pancytokeratin and LCA was identified. The case was diagnosed with malignant melanoma according to the morphological and immunohistochemical findings. No feature was detected in the skin examination of the patient. Hence, the patient was evaluated as primary SMM.
Discussion
They are macroscopically polypoid masses with single or multiple pedicles. They may be occasionally hemorrhagic or necrotic and be easily broken down. They are pigmented due to the presence of intracytoplasmic melanin pigment however 1/3 of the cases have no pigment or slightly pigmented 9.
The pathological diagnosis of SMMs may be difficult because of remarkable cytological and structural differences, mimicking other malignancies and inadequate sampling. Several cell morphologies such as epithelioid, spindle, pleomorphic, rhabdoid, plasmacytoid and small cell have been defined for SMMs. SMM is an excellent mimicker and may mimic many tumors that originate from the sinonasal region in the category of small round blue cell tumor 17,18. NK/T cell lymphoma, plasmacytoma, squamous cell carcinoma, NUT carcinoma, sinonasal undifferentiated carcinoma, olfactory neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, and neuroendocrine carcinoma are the tumors that should be involved in the differential diagnosis of SMM. Since these tumors require different treatment modalities and present different prognoses, the differential diagnosis should be carried out between these tumors and SMM 17,19. Occasionally, its diagnosis may be mixed with chronic sinusitis or a nasal polyp. SMM is a common presentation of a nasal polyp which that would be eliminated as a preliminary procedure with a final diagnosis established on detailed histopathological examination of SMM 9.
A metastasis from cutaneous malignant melanoma to the sinonasal tract should also be involved in the differential diagnosis, although quite rare. The primary SMM may manifest junctional activity and is not encountered in metastatic lesions, however, its absence does not preclude the diagnosis of primary SMM. Intramucosal spread of melanocytes in the adjacent epithelium (epidermal migration) histologically strengthens the possibility of a primary tumor 9,20. Surface epithelium is usually preserved in the metastatic melanomas.
Even though, the presence of melanin pigment supports the diagnosis of SMM, many cases have very limited or no pigment. The positivity of melanocytic marker has not adequate sensitivity and specificity, however they are helpful diagnostic markers. Some of the SMMs may show aberrant differentiation both histomorphologically (e.g., cartilaginous or skeletal muscle differentiation) and immunohistochemically (e.g., staining for epithelial, mesenchymal, or neuroendocrine markers). As a consequence of these facts, these tumors can be delayed or misdiagnosed 17.
Skin melanoma may genetically exhibit the mutations in BRAF, c-kit and NRAS. However, BRAF and c-kit mutations are very rare in the mucosal melanomas whereas NRAS mutation is relatively more frequently seen 21.
SMM requires an aggresive and multimodal treatment while there are many treatment modalities including surgery, radiotherapy, chemotherapy and biological therapy. The complete surgical resection is mandatory to prolong the survival duration, however, implementation of this technique may be occasionally difficult because of complex anatomical structure of the nasal cavity and sinuses as well as the neighborhood of the tumor to the critical structures (skull base, ocular orbit). Radiotherapy and chemotherapy are performed in the advanced-stage patients 22. Despite the improvements in the treatment, the rates of local recurrence, distant metastasis and 5-year survival are 31-85%, 25-50% and 20-30%, respectively 17. SMMs metastasize less frequently to cervical lymph nodes and more frequently to lungs and brain in contrast to squamous cell carcinomas 9.
Conclusion
References
1)Lund VJ, DJ Howard, L Harding, WI Wei. Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 1999; 109: 208-11. 2. Alves ISS, Berriel LGS, Alves RT et al. Sinonasal melanoma: A case report and literature review. Case Rep Oncol Med 2017; 2017: 8201301.
2)Lazarev S, Gupta V, Hu K, Harrison LB, Bakst R. Mucosal melanoma of the headand neck: a systematic review of the literature. Int J Radiat Oncol Biol Phys 2014; 90: 1108-18.
3)Dréno M, Georges M, Espitalier F et al. Sinonasal mucosal melanoma: A 44-case study and literature analysis. Eur Ann Otorhinolarygol Head Neck Dis 2017; 134: 237-42.
4)Gilain L, Houette A, Montalban A, Mom T, Saroul N. Mucosal melanoma of thenasal cavity and paranasal sinuses. Eur Ann Otorhinolaryngol Head Neck Dis 2014; 131: 365-9.
5)Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosalmelanomas: a comprehensive review. Int J Clin Exp Pathol 2012; 5: 739-53.
6)Gunbey HP, Gunbey E, Sayit AT, Aslan K. Magnetic resonance imaging (MRI) appearances of primary amelanotic malign melanoma in the nasal cavity: a rare case. J Clin Diagn Res 2015; 9: TD01-TD03.
7)Patrick RJ, Fenske NA, Messina JL. Primary mucosal melanoma. J Am Acad Dermatol 2007; 56: 828-34. 9. Rinaldo A, Shaha AR, Patel SG, Ferlito A. Primary Mucosal Melanoma of the Nasal Cavity and Paranasal Sinuses, Acta Otolaryngol 2001; 121: 979-82.
8)Freedman HM, DeSanto LW, Devine KD, Weiland LH. Malignant melanoma of the nasal cavity and paranasal sinuses. Arch Otolaryngol 1973; 97: 322-5. 11. Göde S, Turhal G, Tarhan C et al. Primary sinonasal malignant melanoma: effect of clinical and histopathologic prognostic factors on survival. Balkan Med J 2017; 34: 255-62.
9)Clifton N, Harrison L, Bradley PJ, Jones NS. Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review. J Laryngol Otol 2011; 125: 479-85.
10)Hussein MR. Extracutaneous malignant melanomas. Cancer Invest 2008; 26: 516-34.
11)Mangararo AM, Hammond HL, Dalton MJ, Williams TP. Oral melanoma: case reports and a review of the literature, Oral Surg Oral Med Oral Pathol Oral Radiol 1995; 80: 670-6. 15. Lombardo N, Della Corte M, Pelaia C et al. Primary Mucosal Melanoma Presenting with a Unilateral Nasal Obstruction of the Left Inferior Turbinate. Medicina 2021; 57: 359. 16. Kepekci AH, Kig C, Gundogan GI. The evaluation of malignant mucosal melanoma of nasal cavity with a rare occasion. Int J Physiol Pathophysiol Pharmacol 2018; 10: 139-43.
12)Xu X, Palsgrove D, Kurian E, Yan S, Oliai BR, Bishop J. Variable Expression of S100 Protein in Sinonasal Malignant Mucosal Melanoma: A Potential Diagnostic Pitfall. Head Neck Pathol 2020; 14: 929-35.
13)Rooper LM, Bishop JA. Sinonasal small round blue cell tumors: an immunohistochemical approach. Surg Pathol Clin 2017; 10: 103-23.
14)Bridge JA, Bowen JM, Smith RB. The small round blue cell tumors of the sinonasal area. Head Neck Pathol 2010; 4: 84-93.
15)Billings KR, Wang MB, Sercarz JA, Fu YS. Clinical and pathologic distinction between primary and metastatic mucosal melanoma of the head and neck. J Otolaryngol-Head N 1995; 112: 700-6.
16)Bastakoti S, Gautam DK, Upreti SR, Jha N, Dhungana IA. Notorious Mimicker Nasal Melanoma: A Case Report. AJHS 2021; 1: 30-2.
17)Wang T, Huang Y, Lu J, Xiang M. Sinonasal mucosal melanoma: a 10-year experience of 36 cases in China. Ann Transl Med 2020; 8: 1022.
© 2023 Fırat Tıp Dergisi. Tüm hakları saklıdır.

